«Halogenation

Below is an extended Halogenation patents listing. Click here to return to the Halogenation main in depth entry.

Patents :
US Patent No.	Title
7393806	Catalyst composition with monocarboxylic acid ester internal donor and propylene polymerization process
7402595	JNK inhibitor
7402600	Nitroderivatives of cardiovascular agents
7402602	Imidazole derivatives modulating the sodium channels
7402633	Halogenated terpolymers of isobutylene, diolefin monomer and styrenic monomer
7402636	Method and apparatus for decreasing polymer deposition
7402670	Synthesis by chiral diamine-mediated asymmetric alkylation
7402676	Substituted dihydro 3-halo-1H-pyrazole-5-carboxylates their preparation and use
7402682	3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use
7404936	Catalysts, in microchannel apparatus, and reactions using same
7405224	Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
7402588	Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
7402548	Benzoxazole compounds, process for producing the same and herbicides
7399890	Method for the hydrodehalogenation of halogenated meta-cresols
7393842	Pyrazole analogs acting on cannabinoid receptors
7393991	Process for producing internal olefin
7396826	Pharmaceutically active uridine esters
7396836	Pyrimidine compound and medicinal composition thereof
7396952	Process for preparing carbamic ester derivatives
7399725	Perchlorate destruction
7399774	6-substituted nicotinamide derivatives as opioid receptor antagonists
7399780	3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3
7399792	Solid reagents
7399878	Pharmaceutical compounds
7405236	Indole derivatives comprising an acetylene group
7405297	Process for preparing inhibitors of nucleoside metabolism
7411071	Modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
7413784	Thermoplastic vulcanizates for potable water applications
7414031	5-nitro-nucleoside compounds for treating viral infections
7414050	Inhibitors of c-fms kinase
7414059	Pyrazolyl and imidazolyl pyrimidines as CRF antagonists
7414071	Methods of treatment with selective EP4 receptor agonists
7414078	Oral general anesthetics and metabolitically resistant anticonvulsants
7414101	Polymerization processes
7414106	Synthesis of peptide .alpha.-thioesters
7414133	Palladium and platinum complexes
7410926	Polymerization process using a supported, treated catalyst system
7410810	Assay based on doped nanoparticles
7410567	Silica gel compositions containing alkali metals and alkali metal alloys
7405299	Compounds as pharmaceutical agents
7405331	High-purity (fluoroalkyl)benzene derivative and process for producing the same
7407590	Method for removal of biofilm
7407961	Pyrazine derivatives and pharmaceutical use thereof
7407999	Low permeability nanocomposites
7408058	Regioisomerically pure oxochlorins and methods of synthesis
7408061	Rylene dyes
7408084	Process for producing optically active .beta.-amino alcohol
7408100	Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene
7410565	Multi-catalyst selection for chlorided reforming catalyst
7414153	Process for preparation of optically active 1-erythro-2-amino-1-phenyl-1-propanol

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.